Medicines With The Active Ingredient Infliximab - In The Dosage Form Powder (Atc:L04Ab02)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 72080977

  Document Type - Tender Notices

Description - The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient infliximab - in the dosage form powder for the production of an infusion solution concentrate or powder for a concentrate for the production of an infusion solution (ATC: L04AB02) as part of a so-called “open-house model”. Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130 a Paragraph 8 SG

Gt Ref Id - 72080977

Deadline - Aug 31, 2025